Serbia: Medical and donor requirements in surrogacy-related treatment
Short answer
Separate the surrogacy prohibition from the medical and donor rules for ordinary assisted reproduction. Serbia’s Law on Biomedical Assisted Fertilization (BMPO) gives a direct answer on surrogacy: a woman may not be included in a BMPO procedure if she intends to hand the child to a third person after birth, with or without payment. Offering surrogate-mother services is also prohibited.
The statutory prohibition is not limited to paid arrangements
Article 49(18) prohibits including in treatment a woman who intends to hand the child to a third person after birth, with or without payment or any other material or immaterial benefit. It also prohibits offering surrogate-mother services, whether by the woman herself or another person. Labels such as “expenses only”, “family help” or “altruistic” do not change that wording.
The statutory test concerns the intended post-birth transfer in the described context, not genetic links to an intended parent, use of donor gametes or medical screening of the woman carrying the pregnancy. No clinical checklist, donor approval or consent form can override Article 49(18).
This is a statement about Serbian law. It does not decide how another country treats conduct partly abroad, or resolve parentage, citizenship or recognition of a foreign birth record.
Criminal consequences: what the statute says—and what it does not decide
Article 66 sets three to ten years’ imprisonment for the prohibited conduct. It specifies three to twelve years if the offence is committed against a minor; five to fifteen years for serious bodily injury to a donor of reproductive cells or embryos; at least fifteen years if such a donor dies; and at least ten years where the offender engages in these offences or an organised group is involved. The injury/death clauses refer specifically to a donor, not automatically to anyone harmed in a surrogacy arrangement; Serbian criminal counsel must assess their application to the facts.
This does not make every intended parent, donor or person who discussed treatment automatically liable. Serbian criminal counsel must assess conduct, participation, location and jurisdiction; foreign nationality or no payment does not itself remove risk.
If a clinic or intermediary proposes Serbian surrogacy, pause before signing, paying, transferring reproductive material or travelling. Preserve the offer and consult independent Serbian criminal counsel.
Do not confuse surrogacy with ordinary assisted reproduction
The BMPO Law regulates ordinary infertility treatment and certain fertility-preservation procedures, including insemination, IVF and treatment using donated reproductive cells or embryos.
The BMPO Law broadly covers an adult, legally competent woman and man living together as spouses or unmarried partners who meet the statutory conditions and need infertility treatment; exceptionally, an adult, competent woman living alone who meets the law’s conditions; and certain people preserving their own reproductive cells in specified circumstances. A specialist determines the medical indication. This summary does not replace checking every condition in the current Serbian text.
Foreign applicants’ eligibility for ordinary BMPO, relationship or residence evidence, and parentage recognition abroad are separate issues; donor rules or a clinic’s willingness to consult do not decide them.
Recipient assessment and medical consent
For ordinary BMPO, the specialist and eligible patient or couple choose the procedure together. Before written consent, the doctor must explain relevant health information, diagnosis, prognosis and possible consequences and risks for the woman, man and child. The law also requires explanation of other ways to address infertility, including options the centre does not offer, and non-medical options such as adoption or stopping treatment.
Legal and psychosocial counselling is mandatory when donated cells or embryos are used. Consent must be written and given before the procedure, with separate consent for each BMPO performance. Consent cannot waive a legal prohibition, and a psychological assessment or favourable medical opinion cannot authorise prohibited surrogacy.
Ask the clinic to distinguish statutory tests from those indicated by individual medical history and those in its own protocol, and to explain how important results affect treatment.
Donor eligibility: binding baseline and clinical assessment
The BMPO Law requires an egg or sperm donor to be an adult, healthy and legally competent, and to give written consent. A woman may also choose to donate surplus eggs from her own BMPO treatment. The law also requires the centre or reproductive-cell bank to select, test and assess a donor before obtaining cells and to record the results in writing. More detailed criteria and methods are set by ministerial rule.
The donor-selection rule was published in 2019 and amended in 2021. It regulates more than clinic preference: the published framework covers age, medical history, clinical examination, psychological assessment and reproductive-health/testing criteria. The 2021 amendment changed part of the exclusion rules, so older online lists may be materially out of date. The accessible 2019 base text listed male donors up to 40 years and female donors aged 21–34. Because the consolidated text after the 2021 amendment has not been verified, treat these as historical figures, not confirmed current thresholds.
Request the current rule, test panel, validity period of results and written reasons for any rejection. A clinic may add medically justified safeguards but should distinguish them from requirements expressly imposed by law or regulation.
Donor consent, privacy and withdrawal
Donation is voluntary and requires written consent. Before donation, the bank must explain the legal consequences, the donor’s legal relationship to a child conceived using the cells, and the purpose and storage period. Health professionals must explain how donor data will be collected, protected, stored and used. The statutory framework provides confidentiality and anonymity, while allowing limited access to medically relevant information under defined conditions.
A donor may withdraw written consent without giving a reason until use of the cells or embryos begins. Withdrawal must be written and recorded, and staff must check for it before use. A child conceived using donor cells may, from age 15 and if capable of reasoning, request medically relevant donor information for medical reasons; this is not a general right to the donor’s identity.
Ask the bank how it verifies valid, unwithdrawn consent before treatment. Do not promise more secrecy or data access than the law provides.
What donated material may—and may not—be used for
The BMPO Law prohibits trading in reproductive cells or embryos and gain-based intermediation. Narrow statutory exceptions for specified expenses or compensation for excessive harm do not make gametes a commercial product or create a payment route for surrogacy.
Donated cells are permitted only when conception with a partner’s own cells is not reasonably expected, previous BMPO attempts have failed, or donation is needed to prevent a serious hereditary disease. In a couple, donated cells may be used for only one partner. The law also bans mixing cells from multiple donors and using donated eggs and sperm simultaneously.
Article 30 also controls allocation and repeat use. Cells from one donor may be used for one couple or one eligible woman. If the completed BMPO procedures do not result in a birth, the cells may be used for the next eligible recipient; after a child is born, remaining cells may be used only for repeat BMPO for the same couple or woman. Ask the bank to explain the allocation and traceability record.
Import, traceability and records
Under the BMPO Law and the implementing import/export rule, import is permitted when reproductive cells cannot be obtained in Serbia. Import or export must be handled by an authorised reproductive-cell bank; imported cells must come from a bank meeting quality and safety requirements, and the Director of the Administration for Biomedicine issues permission for each case. Implementing rules add requirements for documentation and bank standards.
Serbian law requires traceability of reproductive cells, tissues and embryos from donor to recipient and back, using unique identifiers and records. The centre or bank must retain traceability records for 50 years after use. Serious adverse events and reactions must be tracked and reported, and affected material may need to be withdrawn.
Before cross-border transport, obtain written confirmation of the Serbian bank’s authorisation, the individual import permission, the foreign bank’s status, the identity/transport chain and the receiving centre’s authority to perform the proposed ordinary BMPO procedure. None of these documents legalises surrogacy.
Law versus clinic policy: a practical comparison
Ask who created the requirement and what happens if it is not met.
| Question | Binding legal framework | Clinic policy or case-specific medicine |
|---|---|---|
| May a woman participate if she intends to hand the child to a third person after birth? | No. Article 49(18) prohibits the described participation with or without payment. | An internal protocol or consent form cannot create an exception. |
| Must a donor be assessed and consent? | Yes. Adult status, health, legal capacity, written consent, selection, testing, assessment and written records are required. | A centre may add medically justified tests but should label them accurately. |
| Can donated gametes be bought or freely mixed? | No. Trading and gain-based intermediation are prohibited; use is limited, mixing donors is prohibited, and donated eggs and sperm cannot be used simultaneously. | A clinic cannot waive statutory limits at a patient’s request. |
| Can gametes be imported whenever a patient prefers? | No. Domestic availability, an authorised bank, quality, safety, traceability and case-specific permission matter. | Delivery time and preferred suppliers do not replace legal permission. |
Ask for the exact legal provision behind any claimed “legal requirement”. If it is clinic policy, ask for its clinical rationale, alternatives and whether refusal reflects medical risk or capacity. Neither label changes the statutory surrogacy ban.
A safe pre-clinic checklist
Before spending money or sending reproductive material, follow these steps:
- Define the procedure. Record whether this is ordinary IVF/IUI using own or donated cells, or a plan for a woman to carry and then hand the child to another person.
- Resolve legality first. If the plan includes the prohibited Serbian surrogacy element, stop and obtain independent advice before signing, paying or travelling.
- Verify the provider. Check the centre and bank against current Administration for Biomedicine authorisation records, not just a broker’s logo or advertisement.
- Request the medical basis. Ask which eligibility criteria and tests apply, who interprets results and how abnormal or inconclusive results affect the plan.
- Check donor compliance. Obtain the current selection rule, screening panel, consent process, withdrawal check and traceability arrangements.
- Check imports separately. Obtain individual permission and quality/safety evidence before shipment.
- Get independent advice. Have Serbian counsel review the acts and documents; foreign applicants should also seek advice in the country where parentage or travel documents will later be requested.
How common scenarios should be analysed
Scenario A: a clinic offers “altruistic surrogacy” without a fee. No fee does not solve the issue: Article 49(18) covers arrangements with or without payment or other benefit. “Expenses only” is not a safe harbour.
Scenario B: an intended parent supplies sperm and the carrier uses donor eggs. A genetic link does not remove the prohibition if the woman is included in BMPO intending to hand the child to a third person. Donor eligibility and genetic connection answer different questions.
Scenario C: a single woman or couple seeks ordinary donor IVF for infertility. Ordinary BMPO eligibility, medical indication, donor selection, consent and use limits must be assessed separately. Donor use is not automatically surrogacy, but ordinary IVF eligibility cannot be relabelled to include a carrier who will relinquish the child.
Scenario D: a clinic promises quick delivery from a foreign bank. Ask for the authorised bank, individual Serbian import permission, quality/safety records and traceability. A sales promise or import for another patient does not prove permission in this case.
Questions to obtain in writing
Before paying, ask in writing: (1) what exact procedure will be performed and who will participate; (2) which current legal provisions govern eligibility and donor screening; (3) which tests are statutory, medically indicated in this case or merely internal policy; (4) what written consents are required and how withdrawal is checked before use; (5) which gametes or embryos are proposed and what limits apply; (6) who obtains any individual import permission and when it will be available; and (7) how the centre’s and bank’s authorisations can be independently verified.
If surrogacy is proposed, ask the provider to identify the legal basis it believes permits the arrangement despite Article 49(18). “Other clinics do it”, a foreign-language brochure or an unsigned legal opinion does not answer a statutory prohibition.
Conclusion and limits of this guide
Serbian medical and donor rules regulate ordinary BMPO but do not provide a lawful clinical route around the surrogacy ban. For ordinary treatment, separately verify donor eligibility, testing and assessment, consent and counselling, use limits, provider authorisation and traceability. Clinic policy may add justified safeguards but cannot replace statutory requirements or create a surrogacy exception.
Before reliance, Serbian counsel must confirm the current consolidated law, the donor rule after 2021, any relevant 2026 changes and Article 66’s application to the facts. Foreign applicants need separate advice on eligibility, parentage, citizenship and travel documents. No clinic is endorsed.
Legal sources
- [S1] Law on Biomedical Assisted Fertilization (BMPO), Serbian text; Official Gazette RS 40/2017 and 113/2017 (legal-database reproduction, not an official consolidated text)
- [S2] Rulebook on conditions for importing and exporting reproductive cells and checking quality and safety requirements, Official Gazette RS 27/2019
- [S3] Rulebook on detailed conditions, criteria and method for selection, testing and assessment of donors of reproductive cells and embryos, Official Gazette RS 27/2019 (reproduced Serbian text)
- [S4] Report on the 2021 amendment of the donor-selection rulebook following Ombudsman concerns (secondary source)
